Financhill
Back

Intra-Cellular Therapies Stock Predictions

Intra-Cellular Therapies Stock Forecast

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 35.8% based on the past 11 years of stock performance.
  • Intra-Cellular Therapies has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
  • Is Intra-Cellular Therapies Stock Undervalued?
    The current Intra-Cellular Therapies [ITCI] share price is $126.50. The Score for ITCI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 35.8% based on the past 11 years of stock performance.

Intra-Cellular Therapies Stock Rating

Buy
59
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies overpriced?

  • Intra-Cellular Therapies has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com

52-Week Data

52-Week High:
128.00
52-Week Low:
62.78

Prediction Charts

Market Cap:
13.4B
Price in USD:
126.50
Volume:
6.4M
Beta:
1.04

Technical Analysis

SMA50:
90.50
SMA100:
83.07
SMA200:
77.48
52-Wk Change:
93.28%

Stock Predictions

  • Is Intra-Cellular Therapies stock public?
    Yes, Intra-Cellular Therapies is a publicly traded company.
  • What is the Intra-Cellular Therapies stock quote today?
    The Intra-Cellular Therapies stock price is 126.50 USD today.
  • How to buy Intra-Cellular Therapies stock online?
    You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-30 84.21 83.48 84.86 82.32
Dec-31 83.67 83.52 84.70 83.05
Jan-2 84.16 84.24 84.99 83.75
Jan-3 84.59 83.72 84.64 82.76
Jan-6 83.71 81.78 83.76 81.40
Jan-7 81.68 83.23 84.19 80.83
Jan-8 83.00 82.56 83.05 81.86
Jan-10 86.53 94.87 98.40 86.25
Jan-13 127.95 127.19 128.00 126.90
Jan-14 127.19 126.89 127.45 126.75
Jan-15 126.91 126.71 127.16 126.00
Jan-16 127.00 126.26 127.09 126.25
Jan-17 126.65 126.20 126.74 126.16
Jan-21 126.64 126.50 126.93 126.43

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.